C12N 9/6478
Aspartic endopeptidases
Official title: {Aspartic endopeptidases (3.4.23)}
C12N9/6478 (Aspartic endopeptidases) appears on 253 US grants and 213 published applications in this corpus.
Search patents in C12N- Granted patents
- 253
- Published applications
- 213
- Assignees
- 140
- Inventors
- 576
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 7 | 0 |
| 1991 | 6 | 0 |
| 1992 | 8 | 0 |
| 1993 | 7 | 0 |
| 1994 | 6 | 0 |
| 1995 | 1 | 0 |
| 1996 | 7 | 0 |
| 1997 | 7 | 0 |
| 1998 | 7 | 0 |
| 1999 | 16 | 0 |
| 2000 | 11 | 0 |
| 2001 | 12 | 5 |
| 2002 | 8 | 19 |
| 2003 | 11 | 17 |
| 2004 | 12 | 20 |
| 2005 | 9 | 16 |
| 2006 | 10 | 11 |
| 2007 | 8 | 10 |
| 2008 | 7 | 7 |
| 2009 | 7 | 11 |
| 2010 | 9 | 5 |
| 2011 | 4 | 6 |
| 2012 | 2 | 0 |
| 2013 | 3 | 4 |
| 2014 | 1 | 5 |
| 2015 | 2 | 4 |
| 2016 | 2 | 2 |
| 2017 | 3 | 5 |
| 2018 | 3 | 8 |
| 2019 | 2 | 5 |
| 2020 | 3 | 5 |
| 2021 | 12 | 9 |
| 2022 | 2 | 6 |
| 2023 | 8 | 9 |
| 2024 | 4 | 9 |
| 2025 | 4 | 8 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Gene therapy for neurodegenerative disorders using polynucleotide silencing and replacement6 Oct 2026US 12,753,411 B2The Brigham and Women S Hospital, Inc.
- Gene therapy for Alzheimer's disease16 Dec 2025US 12,497,608 B2The Brigham and Women S Hospital, Inc.
- Compositions comprising digestive enzymes19 Aug 2025US 12,391,935 B2Clara Foods Co.
- Systems and methods for inhibiting γ-secretase production of amyloid-β peptides13 May 2025US 12,297,244 B2Rensselaer Polytechnic Institute
- Host cells comprising a recombinant casein protein and a recombinant kinase protein4 Mar 2025US 12,241,109 B2Nobell Foods, Inc.
- Compositions Comprising Digestive Enzymes3 Sep 2026US 2026/0258387 A1Clara Foods Co.
- Compositions comprising digestive enzymes27 Aug 2026US 2026/0250654 A1Clara Foods Co.
- Composite nanofibrous scaffold enhances in vitro hepatocytes' drug clearance profiles to align with human physiology13 Aug 2026US 2026/0234562 A1University of Maryland, Baltimore County
- Compositions comprising digestive enzymes13 Aug 2026US 2026/0234591 A1Clara Foods Co.
- Modified immune cells and uses thereof19 Feb 2026US 2026/0048120 A1Peking University
Most cited
By later US patents
- Purification and activity assurance of precipitated heterologous proteins229US 4,511,503 AGenentech, Inc. · 1985
- Purification and activity assurance of precipitated heterologous proteins212US 4,511,502 AGenentech, Inc. · 1985
- Purification and activity assurance of precipitated heterologous proteins206US 4,512,922 AGenentech, Inc. · 1985
- Oil-body proteins as carriers of high-value peptides in plants136US 5,650,554 ASemBioSys Genetics Inc. · 1997
- Assays for detecting .beta.-secretase130US 5,942,400 AElan Pharmaceuticals, Inc. · 1999